日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors

一项针对晚期实体瘤患者的首次人体试验、1/2a期、开放标签研究,旨在评估SQ3370(一种首创的基于阿霉素的点击化学疗法)的疗效。

Chawla, S P; Abella, E; Wieland, S; Nguyen, T-H; Srinivasan, S; Alečković, M; Kwatra, V; Subbiah, V; Bui, N; Bhadri, V A; Weiss, M C; Agulnik, M; Ryan, C W; Guminski, A D; Mejía Oneto, J M

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study

凡德他尼联合依维莫司治疗晚期实体瘤患者的安全性和疗效:一项 I 期研究

Cascone, T; Sacks, R L; Subbiah, I M; Drobnitzky, N; Piha-Paul, S A; Hong, D S; Hess, K R; Amini, B; Bhatt, T; Fu, S; Naing, A; Janku, F; Karp, D; Falchook, G S; Conley, A P; Sherman, S I; Meric-Bernstam, F; Ryan, A J; Heymach, J V; Subbiah, V

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma

间变性淋巴瘤激酶抑制剂色瑞替尼对 ALK 重排间变性大细胞淋巴瘤的精准治疗

V Subbiah, S Kuravi, S Ganguly, D R Welch, C J Vivian, M U Mushtaq, A Hegde, S Iyer, A Behrang, S M Ali, R W Madison, J M Venstrom, R A Jensen, J P McGuirk, H M Amin, R Balusu

Selective RET kinase inhibition for patients with RET-altered cancers

针对 RET 变异癌症患者的选择性 RET 激酶抑制

V Subbiah, V Velcheti, B B Tuch, K Ebata, N L Busaidy, M E Cabanillas, L J Wirth, S Stock, S Smith, V Lauriault, S Corsi-Travali, D Henry, M Burkard, R Hamor, K Bouhana, S Winski, R D Wallace, D Hartley, S Rhodes, M Reddy, B J Brandhuber, S Andrews, S M Rothenberg, A Drilon

Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification

血浆游离 DNA 靶向甲基化测序用于癌症检测和分类

L Liu, J M Toung, A F Jassowicz, R Vijayaraghavan, H Kang, R Zhang, K M Kruglyak, H J Huang, T Hinoue, H Shen, N S Salathia, D S Hong, A Naing, V Subbiah, S A Piha-Paul, M Bibikova, G Granger, B Barnes, R Shen, K Gutekunst, S Fu, A M Tsimberidou, C Lu, C Eng, S L Moulder, E S Kopetz, R N Amaria, F M

Different protein sequences can give rise to highly similar folds through different stabilizing interactions

不同的蛋白质序列可以通过不同的稳定相互作用形成高度相似的折叠结构。

Laurents, D V; Subbiah, S; Levitt, M